Intravitreal Infliximab for Proliferative Vitreoretinopathy

Clinical trial NCT04891991 · COMPLETED

Trial details

NCT number: NCT04891991
Sponsor: Cairo University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhegmatogenous Retinal Detachment Proliferative Vitreoretinopathy Retinal Detachment

Start date: 2021-11-26
Primary completion: 2023-11-10
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.